What’s new

In early 2011 we conducted a literature search to find evidence-based guidelines, systematic reviews, meta analyses and randomised controlled trials from the last few years, to bridge the gap between the evidence-based summaries we published in 2007 and the present day.  Listed below are the references that met our inclusion criteria:

  1. Kemp D, E, Gao K, Ganocy S, J, Elhaj O, et al. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and co-occurring substance abuse or dependence. Journal of Clinical Psychiatry  70 (1) (pp 113-121), 2009  Date of Publication: January 2009.
  2. Calabrese J, R, Kemp D, E, Ganocy S, J, et al. A 6-month, pilot, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for dual diagnosis rapid-cycling bipolar disorder. International Journal of Psychiatry in Clinical Practice  11 (SUPPL 1) (pp 15-16), 2007  Date of Publication: May 2007.
  3. Bender RE, Griffin ML, Gallop RJ, Weiss RD. Assessing negative consequences in patients with substance use and bipolar disorders: psychometric properties of the short inventory of problems (SIP). The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions [serial on the Internet]. 2007; (6): Available from: http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/565/CN-00621565/frame.html
  4. Frank E, Boland E, Novick DM, Bizzarri JV, Rucci P. Association between illicit drug and alcohol use and first manic episode. Pharmacology, Biochemistry & Behavior. 2007 2007 Feb;86(2):395-400.
  5. Nomamiukor N BES. Attrition factors in clinical trials of comorbid bipolar and substance-related disorders. Journal of Affective Disorders [serial on the Internet]. 2009; (1-3): Available from: http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/317/CN-00689317/frame.html
  6. Casas M, Franco MD, Goikolea JM, Jimenez-Arriero MA, Martinez-Raga J, Roncero C, et al. Bipolar disorder associated to substance use disorders (dual diagnosis). Systematic review of the scientific evidence and expert consensus. [Review] [46 refs]. Actas Espanolas de Psiquiatria. 2008 2008 Nov-Dec;36(6):350-61.
  7. Lopez-Castroman J, Baca-Garcia E, Oquendo M, A. Bipolar disorder: What effect does treatment adherence have on risk of suicidal behavior? Revista de Psiquiatria y Salud Mental  2 (1) (pp 42-48), 2009  Date of Publication: March 2009.
  8. Sanches R, F, De Azevedo Marques J, M. Cannabis and mood. Revista Brasileira de Psiquiatria  32 (2) (pp 173-180), 2010  Date of Publication: June 2010.
  9. Le Bec P, -Y, Fatseas M, Denis C, Lavie E, Auriacombe M. Cannabis and psychosis: Search of a causal link through a critical and systematic review. Encephale  35 (4) (pp 377-385), 2009  Date of Publication: September 2009.
  10. Gao K, Verduin ML, Kemp DE, Tolliver BK, Ganocy SJ, Elhaj O, et al. Clinical correlates of patients with rapid-cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo-controlled trials. The Journal of clinical psychiatry [serial on the Internet]. 2008; (7): Available from: http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/402/CN-00649402/frame.html
  11. Weiss RD, Griffin ML, Jaffee WB, Bender RE, Graff FS, Gallop RJ, et al. A “community-friendly” version of integrated group therapy for patients with bipolar disorder and substance dependence: a randomized controlled trial. Drug & Alcohol Dependence. 2009 2009 Oct 1;104(3):212-9.
  12. Goldstein B, I, Bukstein O, G. Comorbid substance use disorders among youth with bipolar disorder: Opportunities for early identification and prevention. Journal of Clinical Psychiatry  71 (3) (pp 348-358), 2010  Date of Publication: March 2010.
  13. Schaffer A, Flint A, J, Smith E, Rothschild A, J, et al. Correlates of suicidality among patients with psychotic depression. Suicide & life-threatening behavior  38 (4) (pp 403-414), 2008  Date of Publication: Aug 2008.
  14. Jaffee WB, Griffin ML, Gallop R, Meade CS, Graff F, Bender RE, et al. Depression precipitated by alcohol use in patients with co-occurring bipolar and substance use disorders. Journal of Clinical Psychiatry [serial on the Internet]. 2009; (2): Available from: http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/601/CN-00726601/frame.html
  15. Salloum IM, Douaihy A, Cornelius JR, Kirisci L, Kelly TM, Hayes J. Divalproex utility in bipolar disorder with co-occurring cocaine dependence: A pilot study. Addictive Behaviors [serial on the Internet]. 2007; (2): Available from: http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/981/CN-00590981/frame.html
  16. Stedman M, Pettinati H, M, Brown E, S, Kotz M, et al. A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence. Alcoholism: Clinical and Experimental Research  34 (10) (pp 1822-1831), 2010  Date of Publication: October 2010.
  17. Rounsaville B, J. DSM-V research agenda: Substance abuse/psychosis comorbidity. Schizophrenia Bulletin  33 (4) (pp 947-952), 2007  Date of Publication: Jun 2007.
  18. Evren C, Karatepe H, T, Aydin A, Dalbudak E, Cakmak D. The effect of quetiapine on alcohol/drug dependents and its abuse: A case series and literature review. Klinik Psikofarmakoloji Bulteni  19 (2) (pp 148-154), 2009  Date of Publication: 2009.
  19. Bernardo M, Dodd S, Gama CS, Copolov DL, Dean O, Kohlmann K, et al. Effects of N-acetylcysteine on substance use in bipolar disorder: a randomised placebo-controlled clinical trial. Acta Neuropsychiatrica [serial on the Internet]. 2009; (5): Available from: http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/937/CN-00754937/frame.html
  20. Weinberger A, H, George T, P, Perkins K, A, et al. Effects of topiramate on smoking in patients with schizoaffective disorder, bipolar type. Journal of Clinical Psychopharmacology  28 (2) (pp 247-248), 2008  Date of Publication: Apr 2008.
  21. Gaudiano BA, Uebelacker LA, Miller IW. Impact of remitted substance use disorders on the future course of bipolar I disorder: findings from a clinical trial. Psychiatry Research. 2008 2008 Jul 15;160(1):63-71.
  22. Weiss Rd GML. Integrated group therapy for patients with bipolar disorder and substance dependence [conference abstract]. Alcoholism: Clinical and Experimental Research [serial on the Internet]. 2010: Available from: http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/436/CN-00765436/frame.html
  23. Weiss RD, Griffin ML, Jaffee WB, Bender RE, Graff FS. Integrated group therapy vs. group drug counseling for bipolar disorder and substance dependence: A replication study using front-line drug conselors. Proceedings of the 69th Annual Scientific Meeting of the College on Problems of Drug Dependence; 2007 June 16-21; Quebec City, Canada [serial on the Internet]. 2007: Available from: http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/688/CN-00714688/frame.html
  24. McIntyre R, S, Nguyen H, T, Soczynska J, K, et al. Medical and substance-related comorbidity in bipolar disorder: Translational research and treatment opportunities. Dialogues in Clinical Neuroscience  10 (2) (pp 203-213), 2008  Date of Publication: 2008.
  25. Maremmani I, Pacini M, Lamanna F, Pani PP, Perugi G, Deltito J, et al. Mood stabilizers in the treatment of substance use disorders. [Review] [160 refs]. Cns Spectrums. 2010 2010 Feb;15(2):95-109.
  26. Jaffee WB, Griffin M, McDonald L, Puntins S, Fitzmaurice G, Weiss R. The negative prognostic impact of cannabis dependence in study of patients with bipolar disorder and substance use disorders. Proceedings of the 71th Annual Scientific Meeting of the College on Problems of Drug Dependence; 2009 June 20-25; Reno/Sparks, Nevada, USA [serial on the Internet]. 2009: Available from: http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/665/CN-00726665/frame.html
  27. Brown ES, Gabrielson B, Gu P. A pilot study of quetiapine in patients with bipolar disorder and cocaine dependence. Journal of Dual Diagnosis [serial on the Internet]. 2010; (1): Available from: http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/421/CN-00755421/frame.html
  28. Azorin J, -M, Bowden C, L, Garay R, P, et al. Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism. Neuropsychiatric Disease and Treatment  6 (1) (pp 37-46), 2010  Date of Publication: 2010.
  29. FS G, ML G, RD W. Predictors of dropout from group therapy among patients with bipolar and substance use disorders. Drug & Alcohol Dependence. 2008 2008;94(1-3):272-6.
  30. Osuji IJ, Vera-Bolanos E, Carmody TJ, Brown ES. Pregnenolone for cognition and mood in dual diagnosis patients. Psychiatry Research. 2010 2010 Jul 30;178(2):309-12.
  31. Weinberger AH, Vessicchio JC, Sacco KA, Creeden CL, Chengappa KN, George TP. A preliminary study of sustained-release bupropion for smoking cessation in bipolar disorder. Journal of Clinical Psychopharmacology. 2008 2008 Oct;28(5):584-7.
  32. The prevalence and significance of substance use disorders in bipolar type I and II disorder. [References]. Substance Abuse Treatment, Prevention, and Policy Vol2 Oct 2007, ArtID 29.
  33. Fountoulakis K, N, Gonda X, Siamouli M, Rihmer Z. Psychotherapeutic intervention and suicide risk reduction in bipolar disorder: A review of the evidence. Journal of Affective Disorders  113 (1-2) (pp 21-29), 2009  Date of Publication: February 2009.
  34. Weiss RD, Griffin ML, Kolodziej ME, Greenfield SF, Najavits LM, Daley DC, et al. A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. The American journal of psychiatry [serial on the Internet]. 2007; (1): Available from: http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/547/CN-00577547/frame.html
  35. Brown E, S, Garza M, Carmody T, J. A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders. Journal of Clinical Psychiatry  69 (5) (pp 701-705), 2008  Date of Publication: May 2008.
  36. Brown E, S, Carmody T, J, Schmitz J, M, et al. A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. Alcoholism: Clinical and Experimental Research  33 (11) (pp 1863-1869), 2009  Date of Publication: November 2009.
  37. Brown ES, Gorman AR, Hynan LS. A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence. Journal of Clinical Psychopharmacology. 2007 2007 Oct;27(5):498-502.
  38. Lorberg B, Wilens T, E, Martelon M, Wong P, Parcell T. Reasons for substance use among adolescents with bipolar disorder. American Journal on Addictions  19 (6) (pp 474-480), 2010  Date of Publication: November 2010.
  39. Tolliver BK, McRae AL, Sonne SC, Brady KT. Safety and tolerability of acamprosate in alcohol-dependent individuals with bipolar disorder: an open-label pilot study. Addictive Disorders and their Treatment [serial on the Internet]. 2009; (1): Available from: http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/454/CN-00754454/frame.html
  40. Saxon L, Skagerberg S, Borg S, Hiltunen AJ. Should mood during intravenous alcohol administration be studied as a bi- or unipolar phenomenon? a pilot study. Alcohol. 2010 2010 Aug;44(5):393-400.
  41. QQ T, B M. Treatments for patients with dual diagnosis: a review. Alcoholism: Clinical & Experimental Research. 2007 2007;31(4):513-37.
  42. Women with bipolar disorder who use alcohol and other drugs. [References]. Journal of Addictions Nursing Vol19(2), 2008, pp 55-60.